Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 37

Novel Octameric Resistosome and Immune Mechanism in Wheat

After activation, these NLRs form multi-protein complexes—called resistosomes—that carry out the immune response. Studies have shown that certain resistosomes are pentameric (e.g., ZAR1 and Sr35), whereas others are hexameric (e.g., NRC2 and NRC4). These complexes initiate immune responses by triggering calcium (Ca2+) influx into the cytoplasm. However, the G10 type of CC-NLR (CCG10-NLR) immune receptors constitutes a unique clade among CC-NLRs and its activation mechanism has remained poorly understood.

Now, in a study published in Cell, a research team has revealed a novel octameric resistosome formed by an activated wheat CCG10-NLR immune receptor, which induces Ca2+ influx and immune responses through a unique channel architecture.

The researchers identified the Wheat Autoimmunity 3 (WAI3) gene, which encodes a CCG10-NLR protein. Subsequent analysis revealed that a gain-of-function (GOF) single amino acid mutation in the leucine-rich repeat (LRR) domain leads to autoactivation, providing an opportunity to study the activation mechanism of CCG10-NLR.

After expressing the WAI3 proteins in Nicotiana benthamiana, the researchers used cryo-electron microscopy to resolve the octameric structure of the activated WAI3 resistosome—marking the first time an octameric resistosome has been identified in plants.

The CCG10-NLR WAI3 resistosome differs from known resistosomes both in the number of monomers and in its conformation, representing a novel assembly mechanism for plant NLR resistosomes.

Using Nicotiana benthamiana and animal cell expression systems, the researchers also demonstrated that the WAI3 resistosome induces Ca2+ influx in plants but is not effective in animal cells. ScienceMission sciencenewshighlights.

Continue reading “Novel Octameric Resistosome and Immune Mechanism in Wheat” | >

Ultrastructural preservation of a whole large mammal brain with a protocol compatible with human physician-assisted death

Ultrastructural Preservation of a Whole Large Mammal Brain (bioRxiv, 2026) ⚠️ Preprint – not yet peer-reviewed.

A 2026 preprint builds on over a decade of brain preservation research, demonstrating that whole mammalian brains (pigs) can be preserved with remarkable structural fidelity under near–real-world, end-of-life conditions.

The study refines aldehyde-stabilized cryopreservation (ASC)—a technique previously recognized by the Brain Preservation Foundation. This method combines chemical fixation (aldehydes), cryoprotectants, and controlled cooling to prevent ice damage and preserve neural structure at the nanoscale. — What the study shows.

Whole pig brains preserved with intact cellular and synaptic architecture.

Preservation remains viable even with delayed postmortem intervals (~10 minutes)

Tissue remains perfusable and structurally stable after fixation.

Protocol moves toward clinically realistic implementation, not just lab conditions.

Continue reading “Ultrastructural preservation of a whole large mammal brain with a protocol compatible with human physician-assisted death” | >

The Jellies That Evolved a Different Way To Keep Time

Developmental biologist Tsuyoshi Momose cultures a newly discovered species of jellyfish in a tank of circulating water. Scientists want to understand how these unusual jellies keep time.

The passage of the sun across the sky — dawn, day, dusk, night — drives the clock of life. Some species wake with the sun and sleep with the moon. Others do the opposite, and a few keep odd hours. These naturally driven, 24-hour biological cycles are known as circadian rhythms, and they do more than cue bedtime: They regulate hormones, metabolism, DNA repair, and more. When life falls out of sync, there can be dire consequences for health, reproduction, and survival.

Lacking watches, many species keep time using an internal system — a set of interacting genes and their protein products that effectively keeps track of a 24-hour period — that is calibrated by sunlight. This kind of circadian clock is widespread, found even in single-celled algae, which suggests that biological timekeeping evolved billions of years ago. Across animals, most species have the same genetic system, using genes known as CLOCK, BMAL1, and CRY, or recognizable homologues. This form of biological clock mechanism appears even in ancient lineages, including sponges and some jellyfish.

But is this the only way to do it? In a pea-size jelly off the coast of Japan, biologists are examining a different kind of timekeeping.

The many pathways driving liver inflammation in MASH

Online now: Intra-and extrahepatic inflammation in MASH is driven by various hits such as lipotoxicity, the gut microbiome, and proinflammatory diets. Inflammation contributes to hepatic and systemic complications, including cardiovascular diseases. Beneficial drugs in MASH might target metabolic and inflammatory pathways.

Inflammation is a key driver of this disease, and effective future therapies might have to target metabolic and inflammatory pathways.

Assessment of inflammation, i.e., MASH in humans, is still challenging as it might appear intermittently during the clinical course and could be missed by liver biopsy. Future non-invasive strategies assessing the liver’s inflammatory burden are eagerly awaited.

A safer, more effective atrial fibrillation treatment method using magnetic gel may be on the way

Atrial fibrillation is a common heart condition characterized by a rapid, irregular heartbeat stemming from the heart’s upper chamber. It is a leading cause of stroke from clots that form in a small pouch of the heart called the left atrial appendage (LAA). While several treatment options exist, they have many drawbacks, and risks often remain. But now, researchers have developed a promising new treatment involving magnetic fluids. Their study, published in Nature, describes the new procedure and results from rat and pig studies.

Atrial fibrillation treatment options Blood thinners are a common treatment for atrial fibrillation. However, some patients cannot take them due to an increased risk of bleeding. Another option is closing off the LAA with a device. This is referred to as left atrial appendage occlusion (LAAO). While the devices that are currently available reduce stroke risk, they can leave small leaks and attract clots on or around the device itself. One of these devices is the Watchman occluder—a metallic transcatheter LAAO device.

One reason blocking off the LAA is difficult is that its shape varies from patient to patient, and is often rather odd. Names of these strange and difficult-to-fill shapes include cauliflower, cactus, chicken wing and the most challenging type—the windsock. Some improvements have been made to attempt to fit these shapes better, but issues remain.

Lysosomal defects are emerging as a feature in multiple inflammatory diseases

Barbara J. Vilen & team now identify defective late endosomes and lysosomes (LELs) in patients with active lupus and show reduced LEL function promotes SLE through chronic PI3k activity and SHP-1/SHIP-1 defects:

The figure shows bone marrow-derived macrophages from lupus prone mice (MRL/lpr) have decreased recruitment of pSHIP-1Y1022 (green) to the plasma membrane, indicated by cholera toxin-stained lipid rafts (blue), compared with control mice (B6).

1Department of Microbiology and Immunology and.

2Division of Rheumatology, Allergy, and Immunology, Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.

3Division of Rheumatology and Immunology, Duke University Medical Center, Durham, North Carolina, USA.

Protein atlas connects the biological dots underlying neurodegenerative diseases

Neurodegenerative diseases form a tangled biological web with overlapping molecular signatures and symptoms. To decode this complexity, a multi-institute collaboration led by St. Jude Children’s Research Hospital scientists developed the pan-neurodegeneration atlas (PanNDA). The atlas is a comprehensive survey of neurodegenerative disease “proteomes” containing information about protein levels, modifications, and interactions. This resource, published today in Cell, provides a wide-ranging protein-based outlook to better understand the origins of neurodegenerative diseases and to aid in their diagnosis and treatment.

Neurodegenerative diseases often stem from protein misfolding or accumulation. These errors also disrupt binding partners, upstream and downstream effectors, and any connected pathways. By combining multiple proteomic strategies, co-corresponding authors Junmin Peng, Ph.D., St. Jude Departments of Structural Biology and Developmental Neurobiology, and Bin Zhang, Ph.D., Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, created PanNDA to understand and explore this network and how it is disrupted in these diseases.

Human papilloma virus (HPV) mediated cancers: an insightful update

Human papillomavirus (HPV), a DNA virus, is a well-documented causative agent of several cancers, including cervical, vulvar, vaginal, penile, anal, and head & neck cancers. Major factors contributing to HPV-related cancers include persistent infection and the oncogenic potential of particular HPV genotypes. High-risk HPV strains, particularly HPV-16 and HPV-18, are responsible for over 70% of cervical cancer cases worldwide, as well as a significant proportion of other genital and head and neck cancers. At the molecular level, the oncogenic activity of these viruses is driven by the overexpression of E6 and E7 oncoproteins. These oncoproteins dysregulate the cell cycle, inhibit apoptosis, and promote the accumulation of DNA damage, ultimately transforming normal cells into cancerous ones. This review aims to provide a comprehensive overview of the recent advances in HPV-related cancer biology and epidemiology. The review highlights the molecular pathways of HPV-driven carcinogenesis, focusing on the role of viral oncoproteins in altering host cell targets and disrupting cellular signalling pathways. The review explores the therapeutic potential of these viral proteins, and discusses current diagnostic and treatment strategies for HPV-associated cancers. Furthermore, the review highlights the critical role of HPV in the development of various malignancies, emphasizing the persistent challenges in combating these cancers despite advancements in vaccination and therapeutic strategies. We also emphasize recent breakthroughs in utilizing biomarkers to monitor cancer therapy responses, such as mRNAs, miRNAs, lncRNAs, proteins, and genetic markers. We hope this review will serve as a valuable resource for researchers working on HPV, providing insights that can guide future investigations into this complex virus, which continues to be a major contributor to global morbidity and mortality.

/* */